Your browser doesn't support javascript.
loading
Mycobacterial infection aggravates Helicobacter pylori-induced gastric preneoplastic pathology by redirection of de novo induced Treg cells.
Artola-Borán, Mariela; Fallegger, Angela; Priola, Martina; Jeske, Rima; Waterboer, Tim; Dohlman, Anders B; Shen, Xiling; Wild, Sebastian; He, Jiazhuo; Levesque, Mitchell P; Yousefi, Shida; Simon, Hans-Uwe; Cheng, Phil F; Müller, Anne.
Affiliation
  • Artola-Borán M; Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.
  • Fallegger A; Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.
  • Priola M; Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.
  • Jeske R; Infection and Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
  • Waterboer T; Infection and Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
  • Dohlman AB; Department of Biomedical Engineering, Center for Genomics and Computational Biology, Duke Microbiome Center, Duke University, Durham, NC, USA.
  • Shen X; Department of Biomedical Engineering, Center for Genomics and Computational Biology, Duke Microbiome Center, Duke University, Durham, NC, USA.
  • Wild S; Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.
  • He J; Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.
  • Levesque MP; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
  • Yousefi S; Institute of Pharmacology, University of Bern, Bern, Switzerland.
  • Simon HU; Institute of Pharmacology, University of Bern, Bern, Switzerland; Department of Clinical Immunology and Allergology, Sechenov University, Moscow, Russia; Laboratory of Molecular Immunology, Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia; Institute of Biochemis
  • Cheng PF; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
  • Müller A; Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland. Electronic address: mueller@imcr.uzh.ch.
Cell Rep ; 38(6): 110359, 2022 02 08.
Article in En | MEDLINE | ID: mdl-35139377
ABSTRACT
The two human pathogens Helicobacter pylori and Mycobacterium tuberculosis (Mtb) co-exist in many geographical areas of the world. Here, using a co-infection model of H. pylori and the Mtb relative M. bovis bacillus Calmette-Guérin (BCG), we show that both bacteria affect the colonization and immune control of the respective other pathogen. Co-occurring M. bovis boosts gastric Th1 responses and H. pylori control and aggravates gastric immunopathology. H. pylori in the stomach compromises immune control of M. bovis in the liver and spleen. Prior antibiotic H. pylori eradication or M. bovis-specific immunization reverses the effects of H. pylori. Mechanistically, the mutual effects can be attributed to the redirection of regulatory T cells (Treg cells) to sites of M. bovis infection. Reversal of Treg cell redirection by CXCR3 blockade restores M. bovis control. In conclusion, the simultaneous presence of both pathogens exacerbates the problems associated with each individual infection alone and should possibly be factored into treatment decisions.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Helicobacter pylori / T-Lymphocytes, Regulatory / Mycobacterium Infections / Mycobacterium tuberculosis Type of study: Prognostic_studies Limits: Animals Language: En Journal: Cell Rep Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Helicobacter pylori / T-Lymphocytes, Regulatory / Mycobacterium Infections / Mycobacterium tuberculosis Type of study: Prognostic_studies Limits: Animals Language: En Journal: Cell Rep Year: 2022 Document type: Article Affiliation country: